In the News

August 30, 2016

By Melanie Mason

State Sen. Ed Hernandez's attempt to push through a drug pricing transparency bill sputtered this year, but the West Covina Democrat still wants his colleagues to weigh in on the latest controversy in the cost of prescription drugs: the surging price of EpiPens. 

August 30, 2016

By Sophia Bollag

California lawmakers on Tuesday sent the governor a bill that could help students graduate in four years from California State University schools.

August 26, 2016

By Emily Bazar

State Sen. Ed Hernandez and his wife, Diane, are optometrists.

Diane handles some insurance matters for their practice, and she recently told him that a health plan had emailed to request more information: It wanted confirmation that they were both participating providers, he says.

August 18, 2016

A bill aimed at shedding light on drug costs has been shelved by its author.

On Thursday's Capitol Chat, Capitol Bureau Chief Ben Adler explains why Senator Ed Hernandez decided to stop moving SB 1010 through the Legislature.

SB 1010 was designed to help ensure that healthcare purchasers are notified of price increases for prescription drugs in advance and have information needed to effectively negotiate with drug companies for fair prices.

August 18, 2016

By Melanie Mason and Sophia Bollag

An effort to shed more light on prescription drug prices sputtered in the Legislature on Wednesday, dealing a setback to a burgeoning national movement to rein in healthcare expenses by curbing the cost of medication.

August 17, 2016

By Ben Bradford

A bill that would have required drug companies to notify patients before they increased prices is likely dead at the California Capitol.

The bill’s author, Senator Ed Hernandez, says he will no longer support it, after the Assembly Appropriations committee amended it without his consent.

August 17, 2016

By Ana B. Ibarra

After being approved by a key committee last week, a bill that would have required drug companies to justify treatment costs and price hikes was pulled by its author on Wednesday.